Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results
2019
AbstractObjective: We compared the pharmacokinetic exposure following a single subcutaneous dose of benralizumab 30 mg using either autoinjectors (AI) or accessorized prefilled syringes (APFS). APF...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
7
Citations
NaN
KQI